Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.
about
The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblastsPhosphorylation of Cytochrome c Threonine 28 Regulates Electron Transport Chain Activity in Kidney: IMPLICATIONS FOR AMP KINASEPhenotypic characteristics of diabetic kidney involvement.Renal Oxygenation in the Pathophysiology of Chronic Kidney Disease.Attenuation of hyperlipidemia- and diabetes-induced early-stage apoptosis and late-stage renal dysfunction via administration of fibroblast growth factor-21 is associated with suppression of renal inflammationInteractions between HIF-1α and AMPK in the regulation of cellular hypoxia adaptation in chronic kidney disease.Deletion of Lkb1 in Renal Tubular Epithelial Cells Leads to CKD by Altering Metabolism.Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery.Genetic architecture of human fibrotic diseases: disease risk and disease progression.Sustained kidney biochemical derangement in treated experimental diabetes: a clue to metabolic memory.Activation of AMP-activated protein kinase inhibits ER stress and renal fibrosis.AMPK negatively regulates tensin-dependent integrin activity.The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout miceCardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.Metformin prevents peritendinous fibrosis by inhibiting transforming growth factor-β signaling.Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases.Cross-talk between AMP-activated protein kinase and renin-angiotensin system in uninephrectomised rats.Energy policy of the kidney: launch of AMPK as a novel therapeutic target.
P2860
Q27312584-F508122E-5643-4E58-B8D7-90BFA5305EBEQ28397825-C29D3B40-9DD2-4396-B886-7949465B121BQ33827206-F7766E81-CB8B-4D5E-86A3-EA4905C7B480Q33843362-1F66C642-C842-4D35-85C6-4F5CC30CA5BEQ35070137-A19A7585-27FF-4BC3-8742-2C5457C305D8Q36017602-6C44ACEF-67D2-4DC9-9C92-1595382FF88CQ36514929-9623B920-E3BC-4C03-94E7-781FA25CFD82Q36695298-AB1E0228-F896-49E6-9679-1AD8E7A1A67BQ37400152-515D57E1-8671-4C40-9D76-4123921EDD3BQ37581782-C3017579-7862-4CB0-B4AE-197C146A7480Q38431719-41979690-A5E7-4BB6-9896-8657495EA4E5Q38712389-72BAA0FB-FFE2-45D8-A537-D4CF5098FE77Q41849344-3F9BE887-E978-47D2-B0B7-93AFB7D4B1A4Q42136100-67494892-A0E4-4F4C-A7C4-75F9E5804B7EQ47166636-12B3D682-A6BD-43F3-B580-B2C137E5B112Q47974120-0E03F673-D65F-4036-BC7E-8F4923BE374FQ51353323-1151857F-CFA0-409B-9674-A1C02092445BQ54420876-AE58900A-1F26-4043-B123-5D7C1903872A
P2860
Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induction of AMPK activity cor ...... del of chronic kidney disease.
@en
Induction of AMPK activity cor ...... del of chronic kidney disease.
@nl
type
label
Induction of AMPK activity cor ...... del of chronic kidney disease.
@en
Induction of AMPK activity cor ...... del of chronic kidney disease.
@nl
prefLabel
Induction of AMPK activity cor ...... del of chronic kidney disease.
@en
Induction of AMPK activity cor ...... del of chronic kidney disease.
@nl
P2093
P2860
P1476
Induction of AMPK activity cor ...... del of chronic kidney disease.
@en
P2093
Aihua Deng
Joseph Satriano
Kumar Sharma
Roland C Blantz
P2860
P304
P356
10.1152/AJPRENAL.00293.2013
P577
2013-07-03T00:00:00Z